powerful tool for monitoring engraftment, with a high sensitivity and low false positivity rate. Twenty-seven patients underwent allogeneic bone marrow careful monitoring of engraftment is important because the transplantation from sex-mismatched donors. Eleven had presence of residual host cells may precede the reappear-CML, four AML, three myelodysplasia (MDS), three ALL, ance of the abnormal hematopoietic clone. Classic cytogenand one patient each had thalassemia major, Waldenstrom's etics for detection of X and Y chromosomes in bone marmacroglobulinemia, familial hemophagocytic lymphohistirow cells from sex-mismatched transplant recipients is ocytosis (FHL), severe combined immunodeficiency synlabor-intensive, time-consuming and limited by the number drome (SCID), severe aplastic anemia (SAA), and histiof cells that can be analyzed. To exclude mosaicism at the ocytosis. Fifteen patients received marrow from their HLAlevel of 1%, 300 or more metaphase cells must be examidentical siblings, seven from unrelated donors, two from ined.
The present study was undertaken to investigate the Interphase FISH analysis, utilizing dual color XY probes, was performed on 27 patients following allogeneic efficiency, clinical validity and potential limitations prospectively of interphase FISH analysis after sex-missex-mismatched bone marrow transplantation and on 31 controls. Of the 123 167 examined interphase nuclei, matched BMT utilizing commercially available dual color XY probes. Bone marrow and peripheral blood cells were 63 318 were from 19 of the 21 patients (54 specimens) who engrafted, 31 827 from five of the six patients (29 examined from 27 patients (86 specimens) and 31 normal subject controls. These data were compared with convenspecimens) who relapsed (four) or failed to engraft (one) and 24 703 from the 31 control specimens. In patients tional cytogenetic studies from the same patients. The results obtained demonstrate that interphase FISH is a who engrafted, the mean percentage of host cells was 0.26% between day 29 and 5 years following BMT.
highly reliable, efficient and sensitive technique which provides clinically important information. Routine specimens Microchimerism of 0.7% or less than 1-5 years following BMT was not predictive of relapse. Interphase FISH can be processed within 4 h with analysis of over 1000 interphase nuclei. Both cytogenetics and interphase FISH analysis predicted relapse or failure of engraftment in five of the six evaluable patients. In three of five patients provide valuable information in patients who relapse or fail to engraft. both conventional cytogenetics and interphase FISH of bone marrow cells provided important information regarding engraftment status and degree of chimerism. Keywords: FISH; XY; interphase; cytogenetics; bone
Materials and methods marrow transplantation

Patients
Following allogeneic bone marrow transplantation (BMT)
Twenty-seven patients underwent allogeneic bone marrow careful monitoring of engraftment is important because the transplantation from sex-mismatched donors. Eleven had presence of residual host cells may precede the reappear-CML, four AML, three myelodysplasia (MDS), three ALL, ance of the abnormal hematopoietic clone. Classic cytogenand one patient each had thalassemia major, Waldenstrom's etics for detection of X and Y chromosomes in bone marmacroglobulinemia, familial hemophagocytic lymphohistirow cells from sex-mismatched transplant recipients is ocytosis (FHL), severe combined immunodeficiency synlabor-intensive, time-consuming and limited by the number drome (SCID), severe aplastic anemia (SAA), and histiof cells that can be analyzed. To exclude mosaicism at the ocytosis. Fifteen patients received marrow from their HLAlevel of 1%, 300 or more metaphase cells must be examidentical siblings, seven from unrelated donors, two from ined.
1,2 Obtaining this many metaphase cells from bone cord blood, one received maternal haplo-identical and two marrow following transplantation is nearly impossible in a patients received maternal one antigen mismatched bone routine cytogenetic laboratory. Other methods of detecting marrow. Donor cells were not T cell depleted except for and monitoring chimerism are based on population studies marrow cells from haplo-identical maternal donor for and have either poor sensitivity, a high rate of false positivpatient DM. Two patients (MP and SH) who relapsed were ity, or unproven biological or clinical significance. [3] [4] [5] Fluortreated with adoptive immunotherapy and received periphescence in situ hybridization (FISH) allows the rapid eral blood buffy coat infusions from their donors. screening of large number of cells and is becoming a Three patients were not evaluable (DK and WT in Table 2 and AF in Table 4 ) because they either expired before day 28 following BMT, or follow-up study was not performed. Criteria for engraftment and inclusion in Correspondence: Dr V Najfeld, Tumor Cytogenetics Laboratory, Box Table 4 . Three Grove, IL, USA) mixed with hybridization buffer was of the six patients had MDS, two had AML and one with placed on the slide. The target and probe DNA were corefractory ALL underwent a cord blood transplant but did denatured at 80°C for 1 min and 15 s. Hybridization was not engraft. Patient AF expired on day 29 from venocarried out between 2 and 16 h at 37°C. Post-hybridization occlusive disease but was not evaluated beyond day 14 (and washing was performed for 2 min in 0.4 × SSC pH 7.0, at thus excluded from this analysis). Patient EL expired on 75°C. A centromere enumeration probe (CEP) for chromoday 615 from progressive disease. Evaluation of 31 827 some 8 (Vysis) and a locus-specific probe for chromosome interphase nuclei between day 23 and day 370 showed a 21 band region 21q22.13-22.2 (Vysis) were also used in range in percentages of host cells of 0 to 100%. Host cells one patient who relapsed. The in situ hybridization method in four patients were found in 6.7%, 29.2%, 71% and was according to the manufacturer's protocol. Interphase 99.7%, respectively. Subsequent relapse was confirmed by nuclei were counterstained with DAPI. FITC, Texas Red hematological criteria. In patient AS, who failed to engraft, and DAPI hybridization signals were imaged sequentially 6% of host cells were found on day 23 and by day 41 all using a single-band pass filter. Images were merged using a evaluated cells were of host origin. Cytovision (Applied Imaging, Pittsburgh, PA, USA) digital
Comparison of bone marrow cytogenetics and interphase imaging system. Scoring control cells was performed by FISH in patients who relapsed or failed to engraft is shown two observers using a triple-band pass filter. Scoring of in Table 4 . Patient MP, with myelodysplasia, relapsed on cells from all specimens was performed by the same day 287 when interphase FISH study of bone marrow cells observer. Bone marrow cells from normal donors were used indicated 6.7% cells of host origin. At this time, three of as controls: 21 were male and 10 were female. the eight (37%) evaluated metaphase cells had the host abnormal 49,XX,+8,+8,+21 karyotype. This apparent difference in percentages between cytogenetics and interphase Results FISH was most likely due to the small number of available metaphases. By day 326, when repeat cytogenetic study Table 1 shows the results of FISH analysis performed on was adequate, the interphase FISH and conventional cytobone marrow from 31 controls. The sensitivity of interphase genetics gave similar results (23% vs 22%). The treatment FISH to detect XY in males was 99% and XX in females for the patient's post-transplant relapse was donor buffy was 98.5%. False positive results, such as detection of XX coat infusions. On day 370, following three donor buffy in male controls were found at the frequency of 0.011%.
coat infusions conventional cytogenetics of bone marrow No differences were noted in hybridization efficiency using showed 82% host cells, while interphase FISH of bone mara co-denaturation protocol and decreased hybridization time row showed 28.4% of host cells. to 2 h (data not shown). All studies on specimens from
To determine whether host (XX) cells contained an patients were performed using a co-denaturation protocol.
abnormal copy number of chromosome 8, a co-hybridizBone marrow was investigated in 27 patients who underwent allogeneic, sex-mismatched BMT. Post-transation in situ study was performed using dual color CEP XY in males = 99%; YO in males = 0.2%; XX in males = 0.000%; XX in females = 98.5%; XO in females = 1.4%; XY in females = 0%.
Interphase FISH with XY in BMT V Najfeld et al 831 bone marrow specimens from the same day gave comparable results for patients who were in hematological remission as shown in Table 5 . The same comparison for five specimens from two relapsed patients and one patient probes for chromosomes X and 8 on day 326. The results who failed to engraft showed discrepancy in one specimen obtained showed that 22% of marrow cells and 6.5% of from patient MP. peripheral blood cells had tetrasomy 8 in XX cells. To determine whether abnormal cells with tetrasomy 8 carry an abnormal copy number of chromosome 21, on day 352 Discussion dual color co-hybridization in situ was performed with CEP probes for chromosome 8 and locus-specific probe for chromosome 21. Almost 14% of peripheral blood cells with This study was undertaken to determine whether interphase FISH analysis, utilizing commerical dual color XY probes, tetrasomy 8 also had four copies of band region 21q22. 13 ing BMT a minimum of 30 metaphases can be difficult to obtain. Moreover, conventional cytogenetic analysis of bone marrow cells is a time-consuming and labor-intensive this study, evaluation of 24 703 nuclei from 10 female and 21 male control bone marrow specimens showed XY-spea After the second buffy coat infusion from the donor. b Nine days after the third buffy coat infusion from the donor.
cific signals in 99% of male control cells and XX-specific signals in 98.5% of female control cells. Therefore, in this A comparison of FISH results obtained from peripheral blood and bone marrow on the same day (Table 5) suggests study the sensitivity of the interphase FISH test was 98.5% but the threshold of detecting false positive cells containing that routine studies of patients who are in hematological remission could be performed using peripheral blood specithe opposite sex chromosomes by dual color interphase FISH in normal controls was 0.011%. Reproducibility for mens alone. This suggestion is applicable only if relapse or graft failure is not suspected. dual color XY probe for detection of XX and XY cells was confirmed recently in a retrospective clinical validation Host cells were detected by interphase FISH in four patients who relapsed and in one patient who did not study. 12 In this multi-center study, enumeration of both the X chromosome and Y chromosome was performed on 120 engraft. In two of the two patients metaphase analysis was not available from bone marrow but interphase FISH proslides prepared from two mixtures of hematologically derived human cells with known percentages of XY/XX. 12 vided evidence of host cells. In the other three patients detection of chimerism was compared with standard cytoThe limit of detection for XY was determined to be 1%.
The mean percentage of residual host cells found in genetics and discordant results were obtained in two out of four specimens from one patient. patients who engrafted was 0.26 ± 0.4% in peripheral blood using interphase FISH beyond 4 weeks following BMT.
Cytogenetics and interphase FISH studies were concordant in two of four studies performed on bone marrow cells However, a greater number (0.77 ± 1%) of host cells was found within the first 4 weeks in the peripheral blood.
from patient MP. On day 287 an inadequate number of mitoses prevented the accurate determination of the perBlood specimens were analyzed earlier than marrow and this may explain the difference. For example, in patient AT, centage of host cells. On day 370 a much higher proportion (82%) of host cells was obtained by cytogenetics than by 2.9% of residual host cells were detected on day 20 following BMT in the peripheral blood. In contrast, in a bone interphase FISH (28.4%). These observations may be explained by: (1) only 17 metaphases were available for marrow specimen, 8 days later, 0.6% of host cells were found. Similarly, in patient HJ on day 14, 1.4% of the cells analysis; (2) abnormal host XX cells may have a proliferative advantage over XY normal donor cells in vivo; and (3) in the blood were of host origin, whereas 0.2% were of host origin in bone marrow on day 27. In most patients, on day 370 the patient had already received three buffy coat infusions from the donor. Since the interphase FISH the percentage of residual host cells decreased as the time from BMT increased irrespective of the tissue studied.
constitutively enumerates all cells, irrespective of their proliferative state, it is likely that donor cells after the third Although the results from patient DK, a 28-year-old male with CML in blast crisis were not included in this analysis, infusion were present but did not have a high proliferative fraction. Therefore, both standard metaphase studies, which it is important to note that on day 11 following cord blood BMT, peripheral blood analysis showed 99.9% donor cells.
requires proliferating cells, and interphase FISH, which ascertains the XX/XY genotype of both dividing and nonThis finding demonstrated the efficiency of the preparative regimen in eradicating the leukemic clone and the potential dividing cells, were instrumental in predicting relapse and monitoring engraftment after buffy coat infusions in patient use of cord blood in adult BMT.
Between 0.1% and 0.7% host cells were detected by MP. Similarly, in patients EL and SH, standard cytogenetics revealed a higher proportion of host cells than interphase FISH in five patients (nine specimens) who were between 1 and 5 years post-allogeneic BMT. These small interphase FISH, strongly suggesting that at relapse leukemic cells have a higher proliferative capacity than normal numbers of residual host cells may be explained by longlived T lymphocytes not being eradicated by the preparative donor cells. Moreover, cytogenetics detected further karyotypic evolution in host cells of these three patients regimen. Host bone marrow metaphase cells were not detected, indicating that these residual host cells were not (EL, MP and SH), providing evidence that cytogenetics is instrumental in predicting and confirming relapse. dividing, or were not detected among the 8-100 metaphases studied in each patient. Further follow-up study may eluci-
The results obtained in this study, along with previously published reports using non-commercial probes, 11 as well date whether these residual host cells are predictive of relapse. Microchimerism has been reported in a few cases as studies of X and Y chromosomes in preimplanation embryos and uncultured amniocytes, 15, 16 provide strong that showed no sign of relapse using highly sensitive PCR technique for amplification of Y chromosome-specific evidence that interphase FISH with X and Y probes is a highly sensitive technique that may be useful for monitorsequences. 13 However, Elmeagacli et al 14 reported that the detection of mixed chimerism after BMT may represent ing engraftment after BMT. In addition, quantifiable results, the speed with which the analysis can be completed, and persistence of residual, apparently healthy, host-type cells. In this study, chimerism was detected by PCR amplification the ability to analyze large number of cells make interphase FISH a fundamental tool in molecular cytogenetic laboraof Y chromosome-specific sequences with a sensitivity of 0.001%. These results correlated with the detection of minitories. Its high sensitivity, reproducibility and reliability make interphase FISH an important diagnostic tool. mal residual disease by BCR-ABL mRNA amplification in 28 male patients with CML who received BMT from the Furthermore, these results provide the basis for the use of commercially available dual color probes to monitor opposite sex. In seven patients with mixed chimerism longer than 24 months post-BMT the BCR-ABL transcript engraftment after sex-mismatched BMT by interphase FISH. was no longer detected. Our interphase FISH results of 0.1-0.7% microchimerism, and those of Elmeagacli, provide Finally, standard cytogenetics and interphase FISH used simultaneously may provide different, but important inforpreliminary evidence that host cells present 1-5 years post-BMT may not be associated with hematological relapse.
mation on proliferating and nonproliferating cells regarding 
